Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Astellas Enters Asian Licensing Agreement for Ironwood’s Phase III IBS Therapy with $30M

Agreement includes development and commercialization in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »